Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Liu, Xiaomin  [Clear All Filters]
Journal Article
Zhang B, Zhao M, Zhang X, Zhang X, Liu X, Huang W, Lu S, Xu J, Liu Y, Xu W, et al. The value of circadian heart rate variability for the estimation of obstructive sleep apnea severity in adult males. Sleep Breath. 2024.
Cui X, Huo D, Wang Q, Wang Y, Liu X, Zhao K, You Y, Zhang J, Kang C. RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death Dis. 2024;15(1):98.
Liu X, Zhang Y, Chu Y, Zhao X, Mao L, Zhao S, Lin S, Hui X, Gu P, Xu Y, et al. The natural compound rutaecarpine promotes white adipocyte browning through activation of the AMPK-PRDM16 axis. Biochem Biophys Res Commun. 2021;545:189-194.
Cui X, Wang Q, Liu X, Kang C. Levetiracetam: a potent sword against microglia polarization in gliomas. Clin Cancer Res. 2024.
Ghanam J, Chetty VKumar, Anchan S, Reetz L, Yang Q, Rideau E, Liu X, Lieberwirth I, Wrobeln A, Hoyer P, et al. Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow stem cells. Cell Discov. 2023;9(1):12.
Zhang L, Wei Q, Liu X, Zhang T, Wang S, Zhou L, Zou L, Fan F, Chi H, Sun J, et al. Exosomal microRNA-98-5p from hypoxic bone marrow mesenchymal stem cells inhibits myocardial ischemia-reperfusion injury by reducing TLR4 and activating the PI3K/Akt signaling pathway. Int Immunopharmacol. 2021;101(Pt B):107592.
Wang W, Tan J, Liu X, Guo W, Li M, Liu X, Liu Y, Dai W, Hu L, Wang Y, et al. Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress. Nat Commun. 2023;14(1):6201.
Lebovka I, Mele BHay, Liu X, Zakieva A, Schlamp T, Gursanscky NRau, Merks RMH, Großeholz R, Greb T. Computational modelling of cambium activity provides a regulatory framework for simulating radial plant growth. Elife. 2023;12.
Zhao S, Ali AS, Kong X, Zhang Y, Liu X, Skidmore MA, Forsyth CM, G Savage P, Wu D, Xu Y, et al. 1-Benzyloxy-5-phenyltetrazole derivatives highly active against androgen receptor-dependent prostate cancer cells. Eur J Med Chem. 2022;246:114982.